Identifying Predictors of Hospice Eligibility in Patients With Parkinson Disease

Elizabeth R. Goy, Amanda Bohlig, Julie Carter, Linda Ganzini

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study aims to improve recognition of hospice eligibility for patients with Parkinson disease (PD) by ascertaining which variables have a higher probability of occurring uniquely in 6 to 12 months before death when compared to 18 to 24 months before death. Participants were 339 patients who died who were diagnosed with PD or Parkinsonism and treated with dopaminergic prescriptions for at least 3 years in northwestern US Veterans Affairs medical centers. A range of indicators were compared across 3 time periods (30-36 months, 24-18 months, and 12-6 months before death) using within-subjects repeated measures design. Results indicate that body mass index less than 18, alone or combined with a shift in prescribing (when benefits of dopaminergic medications no longer outweigh their risk of side effects), may signal appropriate timing for hospice referral.

Original languageEnglish (US)
Pages (from-to)29-33
Number of pages5
JournalAmerican Journal of Hospice and Palliative Medicine
Volume32
Issue number1
DOIs
StatePublished - Feb 19 2015

Fingerprint

Hospices
Parkinson Disease
United States Department of Veterans Affairs
Parkinsonian Disorders
Prescriptions
Body Mass Index
Referral and Consultation

Keywords

  • hospice
  • palliative
  • Parkinson disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Identifying Predictors of Hospice Eligibility in Patients With Parkinson Disease. / Goy, Elizabeth R.; Bohlig, Amanda; Carter, Julie; Ganzini, Linda.

In: American Journal of Hospice and Palliative Medicine, Vol. 32, No. 1, 19.02.2015, p. 29-33.

Research output: Contribution to journalArticle

@article{09cd048eb74843048707ae7715228d4b,
title = "Identifying Predictors of Hospice Eligibility in Patients With Parkinson Disease",
abstract = "This study aims to improve recognition of hospice eligibility for patients with Parkinson disease (PD) by ascertaining which variables have a higher probability of occurring uniquely in 6 to 12 months before death when compared to 18 to 24 months before death. Participants were 339 patients who died who were diagnosed with PD or Parkinsonism and treated with dopaminergic prescriptions for at least 3 years in northwestern US Veterans Affairs medical centers. A range of indicators were compared across 3 time periods (30-36 months, 24-18 months, and 12-6 months before death) using within-subjects repeated measures design. Results indicate that body mass index less than 18, alone or combined with a shift in prescribing (when benefits of dopaminergic medications no longer outweigh their risk of side effects), may signal appropriate timing for hospice referral.",
keywords = "hospice, palliative, Parkinson disease",
author = "Goy, {Elizabeth R.} and Amanda Bohlig and Julie Carter and Linda Ganzini",
year = "2015",
month = "2",
day = "19",
doi = "10.1177/1049909113502119",
language = "English (US)",
volume = "32",
pages = "29--33",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Identifying Predictors of Hospice Eligibility in Patients With Parkinson Disease

AU - Goy, Elizabeth R.

AU - Bohlig, Amanda

AU - Carter, Julie

AU - Ganzini, Linda

PY - 2015/2/19

Y1 - 2015/2/19

N2 - This study aims to improve recognition of hospice eligibility for patients with Parkinson disease (PD) by ascertaining which variables have a higher probability of occurring uniquely in 6 to 12 months before death when compared to 18 to 24 months before death. Participants were 339 patients who died who were diagnosed with PD or Parkinsonism and treated with dopaminergic prescriptions for at least 3 years in northwestern US Veterans Affairs medical centers. A range of indicators were compared across 3 time periods (30-36 months, 24-18 months, and 12-6 months before death) using within-subjects repeated measures design. Results indicate that body mass index less than 18, alone or combined with a shift in prescribing (when benefits of dopaminergic medications no longer outweigh their risk of side effects), may signal appropriate timing for hospice referral.

AB - This study aims to improve recognition of hospice eligibility for patients with Parkinson disease (PD) by ascertaining which variables have a higher probability of occurring uniquely in 6 to 12 months before death when compared to 18 to 24 months before death. Participants were 339 patients who died who were diagnosed with PD or Parkinsonism and treated with dopaminergic prescriptions for at least 3 years in northwestern US Veterans Affairs medical centers. A range of indicators were compared across 3 time periods (30-36 months, 24-18 months, and 12-6 months before death) using within-subjects repeated measures design. Results indicate that body mass index less than 18, alone or combined with a shift in prescribing (when benefits of dopaminergic medications no longer outweigh their risk of side effects), may signal appropriate timing for hospice referral.

KW - hospice

KW - palliative

KW - Parkinson disease

UR - http://www.scopus.com/inward/record.url?scp=84920945000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920945000&partnerID=8YFLogxK

U2 - 10.1177/1049909113502119

DO - 10.1177/1049909113502119

M3 - Article

C2 - 23975684

AN - SCOPUS:84920945000

VL - 32

SP - 29

EP - 33

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

IS - 1

ER -